...
首页> 外文期刊>Molecules >Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines
【24h】

Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines

机译:牛乳铁蛋白衍生的抗菌合成肽对MDA-MB-468和MDA-MB-231乳腺癌细胞系具有细胞毒作用

获取原文
           

摘要

Linear, dimeric, tetrameric, and cyclic peptides derived from lactoferricin B, containing the RRWQWR motif, were designed, synthesized, purified, and characterized using RP-HPLC chromatography and MALDI-TOF mass spectrometry. The antibacterial activity of the designed peptides against E. coli (ATCC 11775 and 25922) and their cytotoxic effect against MDA-MB-468 and MDA-MB-231 breast cancer cell lines were evaluated. Dimeric and tetrameric peptides showed higher antibacterial activity in both bacteria strains than linear peptides. The dimeric peptide (RRWQWR)2K-Ahx exhibited the highest antibacterial activity against the tested bacterial strains. Furthermore, the peptides with high antibacterial activity exhibited significant cytotoxic effect against the tested breast cancer cell lines. This cytotoxic effect was fast and dependent on the peptide concentration. The tetrameric molecule containing RRWQWR motif has an optimal cytotoxic effect at a concentration of 22 μM. The evaluated dimeric and tetrameric peptides could be considered as candidates for developing new therapeutic agents against breast cancer. Polyvalence of linear sequences could be considered as a novel and versatile strategy for obtaining molecules with high anticancer activity. View Full-Text
机译:使用RP-HPLC色谱法和MALDI-TOF质谱法设计,合成,纯化和表征衍生自乳铁蛋白B的含有RRWQWR基序的线性,二聚体,四聚体和环状肽。评估了所设计的肽对大肠杆菌的抗菌活性(ATCC 11775和25922)以及它们对MDA-MB-468和MDA-MB-231乳腺癌细胞系的细胞毒性作用。二聚体和四聚体肽在两种细菌菌株中均显示出比线性肽更高的抗菌活性。二聚体肽(RRWQWR)2K-Ahx对测试的细菌菌株表现出最高的抗菌活性。此外,具有高抗菌活性的肽对测试的乳腺癌细胞系表现出显着的细胞毒性作用。这种细胞毒性作用是快速的,并且取决于肽浓度。含有RRWQWR基序的四聚体分子在浓度为22μM时具有最佳的细胞毒性作用。评估的二聚体和四聚体肽可被视为开发针对乳腺癌的新治疗剂的候选药物。线性序列的多价可被视为获得具有高抗癌活性的分子的新颖且通用的策略。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号